r semaglutide PDB-101: Diabetes Mellitus: Diabetes Mellitus: undefined: semaglutide and smoking Loss of
Description
Both drugs can cause stomach-related problems, but these side effects tend to occur more often in people taking tirzepatide

Tirzepatide GLP-1s may also reduce the risk of mortality by 62% in people with type 2 diabetes who undergo a percutaneous coronary intervention (PCI) procedure compared with those taking dulaglutide

In the T3 time point (24 hours), no significant statistical differences were found (H(3) = 1.68, p = 0.642

An example of a non-clinical explanatory reference addressing this topic is the article published by TryShed, which outlines how semaglutides mechanism of action differs from hormonal regulation of the menstrual cycle and why weight change itself may be a contributing factor rather than the drug acting directly on reproductive hormones

By mimicking the natural GLP-1 hormone, it helps regulate appetite and food intake, promoting satiety, slowing gastric emptying, and aiding in insulin secretion
